Chris Baker

1.3k total citations
15 papers, 1.0k citations indexed

About

Chris Baker is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Chris Baker has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Surgery and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Chris Baker's work include Cholesterol and Lipid Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Diet, Metabolism, and Disease (4 papers). Chris Baker is often cited by papers focused on Cholesterol and Lipid Metabolism (5 papers), Peroxisome Proliferator-Activated Receptors (5 papers) and Diet, Metabolism, and Disease (4 papers). Chris Baker collaborates with scholars based in Canada, United States and United Kingdom. Chris Baker's co-authors include Khosrow Adeli, Qiaozhu Su, Mark J. Dekker, Angela C. Rutledge, Mark Naples, Jason J. McDougall, Sarah Farr, Joanne Hsieh, Gustavo Juan Hein and Roger S. Newton and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Chris Baker

15 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Baker Canada 14 513 356 319 304 296 15 1.0k
Cecilia Morgantini Canada 18 587 1.1× 240 0.7× 443 1.4× 334 1.1× 331 1.1× 29 1.3k
Anja Kerksiek Germany 16 255 0.5× 401 1.1× 434 1.4× 365 1.2× 192 0.6× 27 1.0k
Ewa Harasim‐Symbor Poland 19 316 0.6× 267 0.8× 185 0.6× 482 1.6× 290 1.0× 71 1.2k
Véronique Fauveau France 14 393 0.8× 447 1.3× 624 2.0× 544 1.8× 490 1.7× 16 1.4k
Mark Naples Canada 26 624 1.2× 457 1.3× 471 1.5× 576 1.9× 289 1.0× 31 1.5k
Adam B. Mayerson United States 7 464 0.9× 625 1.8× 239 0.7× 713 2.3× 587 2.0× 9 1.6k
Sarah R. Sikkema Canada 7 219 0.4× 361 1.0× 287 0.9× 678 2.2× 342 1.2× 7 1.1k
Núria Roglans Spain 24 860 1.7× 853 2.4× 267 0.8× 517 1.7× 580 2.0× 61 1.7k
Esther Guiu‐Jurado Spain 19 228 0.4× 588 1.7× 169 0.5× 308 1.0× 368 1.2× 31 1.1k
Wanda Velez‐Carrasco United States 12 296 0.6× 267 0.8× 258 0.8× 359 1.2× 345 1.2× 13 963

Countries citing papers authored by Chris Baker

Since Specialization
Citations

This map shows the geographic impact of Chris Baker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Baker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Baker more than expected).

Fields of papers citing papers by Chris Baker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Baker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Baker. The network helps show where Chris Baker may publish in the future.

Co-authorship network of co-authors of Chris Baker

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Baker. A scholar is included among the top collaborators of Chris Baker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Baker. Chris Baker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Farr, Sarah, et al.. (2020). Bile acid treatment and FXR agonism lower postprandial lipemia in mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 318(4). G682–G693. 20 indexed citations
2.
Lino, Marsel, et al.. (2015). Intestinal scavenger receptor class B type I as a novel regulator of chylomicron production in healthy and diet-induced obese states. American Journal of Physiology-Gastrointestinal and Liver Physiology. 309(5). G350–G359. 20 indexed citations
3.
Su, Qiaozhu, Chris Baker, Patricia Christian, et al.. (2014). Hepatic mitochondrial and ER stress induced by defective PPARα signaling in the pathogenesis of hepatic steatosis. American Journal of Physiology-Endocrinology and Metabolism. 306(11). E1264–E1273. 65 indexed citations
4.
Farr, Sarah, Chris Baker, Mark Naples, Jennifer Taher, & Khosrow Adeli. (2014). Abstract 429: Central Glucagon-Like Peptide-1 Reduces Intestinal Chylomicron Production via Melanocortin-4-Receptor Signaling. Arteriosclerosis Thrombosis and Vascular Biology. 34(suppl_1). 1 indexed citations
5.
6.
Sniderman, Allan D., Mark Naples, Chris Baker, et al.. (2013). Hepatic Cholesterol Homeostasis. Arteriosclerosis Thrombosis and Vascular Biology. 33(11). 2481–2490. 25 indexed citations
7.
Pinkosky, Stephen L., С. И. Филиппов, Rahul Srivastava, et al.. (2012). AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism. Journal of Lipid Research. 54(1). 134–151. 191 indexed citations
8.
Li, Lixin, Lu Liu, M. Anwar Hossain, et al.. (2012). Lecithin:Cholesterol Acyltransferase Deficiency Protects against Cholesterol-induced Hepatic Endoplasmic Reticulum Stress in Mice. Journal of Biological Chemistry. 287(24). 20755–20768. 52 indexed citations
9.
Hein, Gustavo Juan, Chris Baker, Joanne Hsieh, Sarah Farr, & Khosrow Adeli. (2012). GLP-1 and GLP-2 as Yin and Yang of Intestinal Lipoprotein Production. Diabetes. 62(2). 373–381. 91 indexed citations
10.
Naples, Mark, Chris Baker, Marsel Lino, et al.. (2012). Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance. American Journal of Physiology-Gastrointestinal and Liver Physiology. 302(9). G1043–G1052. 44 indexed citations
11.
Baker, Chris, Marsel Lino, Bernardo L. Trigatti, et al.. (2011). Intestinal SR-BI is upregulated in insulin-resistant states and is associated with overproduction of intestinal apoB48-containing lipoproteins. American Journal of Physiology-Gastrointestinal and Liver Physiology. 301(2). G326–G337. 34 indexed citations
12.
Dekker, Mark J., Qiaozhu Su, Chris Baker, Angela C. Rutledge, & Khosrow Adeli. (2010). Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. American Journal of Physiology-Endocrinology and Metabolism. 299(5). E685–E694. 333 indexed citations
13.
Baker, Chris, et al.. (2009). LXRα activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. American Journal of Physiology-Gastrointestinal and Liver Physiology. 297(2). G323–G332. 35 indexed citations
14.
McDougall, Jason J., Chris Baker, & Petra M. Hermann. (2004). Attenuation of Knee Joint Inflammation by Peripherally Administered Endomorphin-1. Journal of Molecular Neuroscience. 22(1-2). 125–138. 32 indexed citations
15.
Baker, Chris & Jason J. McDougall. (2004). The cannabinomimetic arachidonyl‐2‐chloroethylamide (ACEA) acts on capsaicin‐sensitive TRPV1 receptors but not cannabinoid receptors in rat joints. British Journal of Pharmacology. 142(8). 1361–1367. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cecilia Morgantini Breakdown of academic impact, for papers by Anja Kerksiek Breakdown of academic impact, for papers by Ewa Harasim‐Symbor Breakdown of academic impact, for papers by Véronique Fauveau Breakdown of academic impact, for papers by Mark Naples Breakdown of academic impact, for papers by Adam B. Mayerson Breakdown of academic impact, for papers by Sarah R. Sikkema Breakdown of academic impact, for papers by Núria Roglans Breakdown of academic impact, for papers by Esther Guiu‐Jurado Breakdown of academic impact, for papers by Wanda Velez‐Carrasco
Rankless by CCL
2026